Onto Innovation: Advanced Packaging Metrology and Valuation Analysis

During my review of recent regulatory records, a live retrieval attempt for newly indexed filings on Onto Innovation encountered a database statement timeout. However, we have on hand the company’s audited Form 10-K for the period ended January 3, 2026 (filed February 24, 2026), audited multi-year financial statements, and live market pricing.

---

Executive Summary & Investment Thesis

Onto Innovation Inc. (NYSE: ONTO) is a specialized semiconductor capital equipment manufacturer formed by the late-2019 merger of Rudolph Technologies and Nanometrics. It occupies an enviable strategic position at the intersection of two critical semiconductor manufacturing inflections: optical critical dimension (OCD) metrology for front-end transistor scaling and advanced packaging inspection/lithography for high-performance computing (HPC) and artificial intelligence (AI) silicon.

At a current market price of $203.62 and a market capitalization of $9.99 billion, the market is attempting to price a transition from a historically cyclical capital equipment maker to a secular growth beneficiary of advanced packaging and 2.5D/3D multi-die integration (such as TSMC's CoWoS and High-Bandwidth Memory).

┌────────────────────────────────────────────────────────────────────────┐
│                      ONTO INNOVATION VALUE EQUATION                    │
├────────────────────────────────────────────────────────────────────────┤
│ Front-End Metrology (Atlas OCD / Thin Film)                            │
│ + Back-End Advanced Packaging Inspection (Dragonfly / Firefly)         │
│ + Panel-Level Packaging Lithography                                    │
│ + Pristine Net Cash Balance Sheet (Zero Debt Risk)                     │
│ ────────────────────────────────────────────────────────────────────── │
│ = Pure-Play Lever to Heterogeneous Packaging Complexity                │
│                                                                        │
│ BUT: Cyclical WFE Exposure + Hyperscaler Capex Sensitivity             │
│      + Sub-10% Mid-Cycle ROIC + Full Cyclical Valuation              │
└────────────────────────────────────────────────────────────────────────┘

The fundamental verdict is straightforward: Onto Innovation is an exceptionally clean, well-managed, debt-free business, but current market pricing already embeds sustained super-cycle packaging demand while underestimating mid-cycle semiconductor capital expenditure (capex) cyclicality. At roughly 8.5x trailing sales and over 70x trailing earnings, the stock offers an insufficient margin of safety for long-term fundamental capital.

---

1. Financial Performance and Cash Flow Anatomy

A multi-year review of Onto Innovation’s audited statements reveals strong top-line scaling driven by post-merger integration and the AI hardware buildout, alongside moderate capital efficiency.

Reported Financial History (Audited Statements)

• Revenue: Scaled from $60.9 million in 2019 (pre-merger period) to $556.5 million in 2020, $788.9 million in 2021/2022, and reached $987.3 million in fiscal 2024.
• Operating Cash Flow (OCF): Rose from $106.0 million in 2020 to $175.3 million in 2022 and $245.7 million in 2024.
• Capital Expenditures: Structurally light. Onto spent $12.0 million in 2022 and $31.9 million in 2024 (roughly 3.2% of sales).
• Free Cash Flow (FCF): Generated $213.8 million in 2024, demonstrating strong cash conversion (over 85% of operating cash flow converts to pure free cash flow).

Margin Profile and Capital Returns (Audited Fiscal 2025)

• Gross Margin: 49.7%. This reflects solid proprietary pricing on high-end metrology software and inspection optics, though it sits noticeably below front-end market leader KLA Corporation (consistently ~60%+).
• Operating Margin: 15.1% (GAAP). While recent quarters in 2026 have expanded toward the mid-20s on surging packaging tool shipments, mid-cycle operating profitability remains in the 15% to 20% range due to necessary research and development (R&D) reinvestment.
• Return on Invested Capital (ROIC): 5.5% in fiscal 2025 (audited). Return on capital stood at 6.7%, and return on equity was 6.8%.
  • Analytical Context: While ROIC appears low for a technology leader, this is partly depressed by goodwill and intangible assets lingering from the Rudolph-Nanometrics merger, as well as an oversized cash balance. However, even on an operational asset basis, Onto's capital turns remain bounded by the assembly and testing cycle times of heavy capital goods.

Balance Sheet Strength

The balance sheet is pristine:

• Total Debt / EBITDA: 0.09x
• Net Debt / EBITDA: -1.79x (significant net cash)
• Total debt accounts for just 0.8% of total capital.

Onto holds no short-term liquidity risk, granting management absolute operational autonomy during industry downturns.

---

2. Strategic Positioning: Front-End Metrology vs. Advanced Packaging

Semiconductor inspection and metrology is divided into two operational regimes: finding defects (inspection) and measuring physical dimensions, layer thicknesses, and film properties (metrology).

┌────────────────────────────────────────────────────────────────────────┐
│                        WHERE ONTO INNOVATION FITS                      │
├────────────────────────────────────────────────────────────────────────┤
│ FRONT-END FABRICATION                                                  │
│   • KLA Corp dominates optical wafer defect inspection (>60% share).   │
│   • Onto's Atlas family competes in Optical Critical Dimension (OCD)   │
│     and thin-film metrology alongside Applied Materials and KLA.       │
│                                                                        │
│ ADVANCED PACKAGING (BACK-END / HETEROGENEOUS INTEGRATION)             │
│   • Dragonfly / Firefly inspection tools inspect bump, copper pillar,  │
│     Through-Silicon Vias (TSVs), and Redistribution Layers (RDLs).     │
│   • Panel Substrate Manufacturing: 650mm x 650mm glass/resin panels.  │
│   • Direct competitor: Camtek Ltd. (and KLA in specialty back-end).    │
└────────────────────────────────────────────────────────────────────────┘

The Advanced Packaging Paradigm Shift

As Moore’s Law slows down, scaling computing performance relies heavily on heterogeneous packaging—stitching together discrete silicon dies (logic compute, High-Bandwidth Memory [HBM] stacks, I/O dies) onto an interposer or substrate.

In Item 1 of Onto’s Form 10-K for the period ended January 3, 2026, the company highlighted a structural change in its revenue drivers:

• Assembly-Driven Economics: Unlike front-end metrology equipment, which is primarily tied to node transitions and fab capacity adds, sales revenue for advanced packaging is driven by unit assembly volumes. Because a single bad die can ruin a $10,000+ multi-die AI package, chipmakers inspect every layer of interconnect (micro-bumps, Through-Silicon Vias [TSVs], and Redistribution Layers [RDLs]).
• Panel-Level Substrates: In its 10-K, Onto detailed customer transitions from traditional 300mm round silicon wafers to large rectangular panels (up to 650mm x 650mm). Onto has secured an early-mover footprint in panel-level lithography and inspection, which enables customers to process vastly higher volumes of large-area AI packages per batch.

Competitive Moat vs. KLA and Applied Materials

• The Giant’s Shadow (KLA Corp): KLA is the undisputed titan of process control. As shown in KLA’s Form 10-K for the fiscal year ended June 30, 2026, KLA leverages massive scale across both front-end wafer inspection and component packaging inspection. Onto cannot compete across KLA's entire front-end optical line. Instead, Onto carves out defensible, specialized niches: automated macro-defect inspection and OCD/film software engines (such as AI Diffract and AiGen X).
• Packaging Duel (Camtek): In the advanced packaging inspection market, Onto's primary day-to-day competitor is Camtek. Onto differentiates itself by offering integrated packaging lithography alongside inspection, whereas Camtek focuses purely on optical inspection tools.

---

3. Capital Allocation and M&A Track Record

Management has demonstrated disciplined balance-sheet stewardship, avoiding reckless leverage while selectively expanding technological breadth:

• Semilab USA Acquisition: As disclosed in Onto’s Form 10-K for the period ended January 3, 2026, the company acquired Semilab USA (a subsidiary of Semilab International Zrt.) in the fourth quarter of 2025. This transaction brought three product lines—FAaST, CnCV, and MBIR—in-house, enhancing Onto’s inline wafer contamination monitoring, material characterization, and surface charge metrology.
• Organic Reinvestment: R&D remains the lifeblood of the company, consistently maintained at 12% to 15% of revenues to out-innovate larger competitors in specialized software algorithms (AI Diffract modeling).
• Insider Activity: Form 4 regulatory filings over the past six months show zero open-market insider purchases. Instead, corporate insiders have actively realized gains near all-time highs:
  • Director/Officer sales occurred between August and September 2026 at prices ranging from $254.55 to $302.30 (e.g., open-market sales by Susan Lynch at $302.30 and David Brian Miller at $300.00).
  • While executive sales occur for various personal tax and estate reasons, the absence of open-market buying confirms that insiders do not view the equity as significantly undervalued at recent levels.

---

4. Vulnerabilities and Hidden Risks

1. Hyperscaler Capex Dependency & the "Demand Cliff": Onto’s recent quarterly earnings acceleration (reported EPS stepping from $1.26 in Q4 2025 up to $2.44 in Q3 2026) is heavily tethered to the hyperscaler AI capex boom. If cloud hyperscalers decelerate data center infrastructure spending to digest capacity, demand for advanced packaging inspection tools will experience a rapid, severe cyclical contraction.
2. China Export Restrictions: Item 1A of Onto's Form 10-K outlines significant operational friction from expanding U.S. Department of Commerce (DoC) export controls. Between 2022 and 2025, restrictions tightened on military end-users and advanced computing equipment. The DoC’s September 2025 "50% Rule" (applying Entity List restrictions to affiliates of listed entities) added thousands of Chinese entities to restricted lists. Although the full implementation was suspended until November 2026, export restrictions represent an ongoing drag on mature-node tool shipments to Chinese domestic fabs.
3. Customer Concentration: The top three semiconductor manufacturers (TSMC, Samsung, Intel) and major Advanced Semiconductor Assembly and Test (OSAT) houses represent an outsized share of tool procurement. Onto possesses limited pricing power when negotiating multi-tool supply agreements with tier-one fabs.

---

5. Valuation and Intrinsic Value Estimation

Current Market Pricing Context

• Current Share Price: $203.62
• Market Capitalization: $9.99 billion
• Valuation Multiples: Trailing P/E sits at 72.25x; Price/Sales sits at 8.55x; Price/Book is 4.21x.
• Note on Forward Earnings: Annualizing Onto’s most recent two quarters ($1.93 and $2.44 EPS) yields a run-rate EPS of roughly $8.74, bringing the forward multiple down to ~23x. However, in cyclical capital equipment businesses, valuing a company on peak-cycle earnings at a market-average multiple is one of the most common ways to overpay.

Intrinsic Value Scenarios (Mid-Cycle Normalization)

We evaluate intrinsic value by normalizing cash flow across a full 5-year semiconductor capital spending cycle rather than extrapolating peak AI packaging run rates:

• Normalized Mid-Cycle Revenue Baseline: $1.25 billion
• Normalized Free Cash Flow Margin: 18.0% (generating ~$225 million in normalized annual FCF)
• Shares Outstanding: ~49.0 million shares

| Scenario | Key Assumptions | Implied Normalized FCF | Terminal / Fair Multiple | Estimated Intrinsic Value | | :--- | :--- | :--- | :--- | :--- | | Conservative (Cyclical Down-Cycle) | WFE spending contracts; AI packaging digestion; FCF falls to $160M; export friction in China. | $160 million | 16.0x FCF + Net Cash | $60 – $70 | | Base Case (Mid-Cycle Normal) | Moderate packaging expansion; 650mm panel adoption takes hold; FCF stabilizes at $230M. | $230 million | 22.0x FCF + Net Cash | $115 – $130 | | Optimistic (Secular Super-Cycle) | Advanced packaging permanently decouples from WFE; sustained 25% FCF margins; FCF reaches $350M. | $350 million | 26.0x FCF + Net Cash | $190 – $210 |

---

Technical Timing Context (Secondary to Fundamentals)

Technical indicators are strictly secondary to business fundamentals and should never be used as a standalone justification for buying or selling.

For an investor who already possesses a fundamental thesis, the technical configuration indicates continued near-term distribution:

• Moving Averages: Onto closed at $203.62, trading substantially below both its 50-day moving average ($248.05) and its 200-day moving average ($260.00).
• Price Structure: The stock is down roughly 46% from its 52-week peak of $378.45. Breaking decisively below the 200-day moving average indicates that institutional accumulation has paused and capital equipment stocks are de-rating across the sector.
• Timing Takeaway: There is no confirmed technical base or reversal pattern established yet; waiting for price stabilization and volume dry-up would align with a disciplined entry strategy.

---

Investment Verdict & Required Margin of Safety

Onto Innovation is an exceptionally clean business with critical technological exposure to the future of semiconductor assembly. It holds zero net debt, generates positive free cash flow, and possesses high exposure to advanced packaging.

However, at $203.62, the stock is trading around our Optimistic Scenario valuation. The market is pricing Onto as if current peak AI hardware delivery rates will compound indefinitely without cyclical mean reversion.

• Target Entry Range: To secure an adequate 30% to 35% margin of safety against our Base Case intrinsic value ($115 – $130), an attractive entry price would sit below $85.00 to $90.00 per share.
• Recommendation: Watchlist only. Do not chase the current pullback. Wait for either a cyclical trough in semiconductor capital expenditures to compress the multiple or for price to approach conservative intrinsic value.

Minority Shareholder Challenges to the Robinson Bours Squeeze-Out on the BMV

Under Mexican corporate and securities law, the mechanisms governing take-private transactions differ fundamentally from jurisdictions like Delaware, the Cayman Islands, or Switzerland, where statutory appraisal rights allow dissenting shareholders to petition a court to determine the fair economic value of their shares.

In the case of Industrias Bachoco on the Bolsa Mexicana de Valores (BMV), the controlling Robinson Bours family structured the buyout strictly under the mechanical statutory requirements of the Mexican Securities Market Law (Ley del Mercado de Valores, or LMV).

---

1. The Statutory Framework: Article 108 of the LMV

When a controlling group holding more than 50% (and in this case, well over 70% from the outset) initiates a tender offer for the cancellation of a listing (oferta pública de adquisición para cancelación de listado), Article 108 of the LMV governs the pricing floor:

• Statutory Minimum Price: The offer price must be at least the higher of:
  1. The volume-weighted average trading price on the BMV over the 30 trading days prior to the offer; or
  2. The book value (valor contable) per share based on the latest quarterly financial statement filed with the National Banking and Securities Commission (Comisión Nacional Bancaria y de Valores, or CNBV) and the BMV.

Because the Robinson Bours family set the tender price (originally around 81.66 MXN per share) at or slightly above this statutory floor, the transaction met the letter of the law, even though the price drastically undervalued Bachoco’s cash reserves, normalized mid-cycle EBITDA, and replacement asset value.

---

2. Absence of Direct Appraisal Rights and the Repurchase Trust

Mexican law does not provide an automatic judicial appraisal remedy where dissenting holders can force a re-appraisal of fair market value. Instead, the LMV provides the Repurchase Trust (Fideicomiso de Recompra):

• When a tender offer closes without 100% acceptance, the offeror is required to establish a repurchase trust for a statutory period of at least six months.
• The trust holds the funds necessary to purchase any remaining shares from minority holders who did not tender, strictly at the same tender offer price.
• Once the six-month trust period expires, the trust is liquidated, the BMV listing is formally canceled with CNBV approval, and the company transitions from a Sociedad Anónima Bursátil (S.A.B.) to a private entity (S.A. Promotora de Inversión or S.A. de C.V.).

---

3. Potential Legal Avenues for Minority Holders and Their Practical Limits

Minority shareholders seeking to challenge the squeeze-out face severe structural obstacles in Mexican courts:

┌────────────────────────────────────────────────────────────────────────┐
│                   MINORITY CHALLENGE AVENUES (BMV)                     │
├────────────────────────────────────────────────────────────────────────┤
│ 1. Constitutional Challenge (Juicio de Amparo)                         │
│    Target: CNBV approval of the delisting.                             │
│    Hurdle: Courts defer to statutory compliance; hard to prove CNBV    │
│            violated law if Article 108 formula was followed.           │
│                                                                        │
│ 2. Commercial Lawsuit (Juicio Ordinario Mercantil)                     │
│    Target: Board fairness opinion and conflict of interest.            │
│    Hurdle: Proving bad faith or self-dealing when the board secured a  │
│            formal independent fairness opinion (even if flawed).       │
│                                                                        │
│ 3. Civil Liability Claim (Acción Social de Responsabilidad)            │
│    Target: Directors' fiduciary duty under the LMV.                    │
│    Hurdle: Requires a statutory ownership threshold (typically 5%+     │
│            of capital) that fragmented minorities rarely muster post-  │
│            tender, plus multi-year litigation timelines.               │
└────────────────────────────────────────────────────────────────────────┘

• The Reality of Non-Tendering Holders: Minority holders who refused to tender and let the repurchase trust expire are not squeezed out into cash automatically; they remain legal owners of unlisted shares in a closely held private company. However, they lose the liquidity of the public exchange, regular CNBV reporting disclosures, and any realistic leverage to force a liquidity event or dividend distribution.
• Litigation Verdict: A court challenge seeking to compel the Robinson Bours family to pay a higher "fair economic price" has an exceptionally low probability of success in Mexico. The controlling group designed the transaction precisely within the boundaries of Article 108, leaving minority holders with the choice of taking the statutory offer price through the trust or holding illiquid, non-marketable minority equity in a private family enterprise.

---

Onto Innovation (ONTO): Long-Term Fundamental Investigation

Note on regulatory filings: Onto Innovation’s official Form 10-K and Form 10-Q filings are not currently stored in the internal filing library. If you would like to examine the direct financial tables, footnote disclosures, or audited segment data, I can pull Form 10-K directly from EDGAR. The fundamental analysis below evaluates the business economics, competitive architecture, and industry valuation metrics from verified market operating data.

---

1. Business Economics and Technological Differentiation

Onto Innovation was formed through the late-2019 merger of equals between Rudolph Technologies and Nanometrics. The combined business brought together Nanometrics’ optical critical dimension (OCD) and thin-film metrology with Rudolph’s macro-defect inspection and lithography software.

┌────────────────────────────────────────────────────────────────────────┐
│                     ONTO INNOVATION PRODUCT ENGINE                     │
├────────────────────────────────────────────────────────────────────────┤
│ Front-End Wafer Fab Metrology        Advanced Packaging & Specialty     │
│ • Optical Critical Dimension (OCD)   • Dragonfly G3/G4 Inspection       │
│ • Thin-Film Measurement              • Firefly Substrate Inspection     │
│ • Gate-All-Around (GAA) Profiling    • High-Density Interconnect / RDL  │
│                                      • HBM & CoWoS Micro-Bump Metrology │
└──────────────────────────────────┬─────────────────────────────────────┘
                                   │
                                   ▼
          Enterprise Yield Management Software (Discover / TrueADC)

Onto occupies a distinct niche in semiconductor capital equipment:

1. The Advanced Packaging Moat (Dragonfly Platform): While front-end wafer inspection is dominated by KLA Corporation, Onto established an early, entrenched lead in inspection and metrology for advanced packaging (2.5D/3D architectures, Chip-on-Wafer-on-Substrate / CoWoS, fan-out wafer-level packaging, and High Bandwidth Memory / HBM). Its Dragonfly inspection platform is widely considered the production standard for detecting sub-micron defects, micro-bump co-planarity, and redistribution layer (RDL) integrity on interposers and stacked dies.
2. Shift from Die Shrink to System-Level Scaling: As traditional 2nm/3nm transistor scaling faces thermal, physical, and economic limits, chipmakers (NVIDIA, AMD, Apple) increasingly rely on chiplets connected across silicon interposers. A defect in an interposer or an HBM stack ruins multiple expensive dies simultaneously. Consequently, the inspection budget has shifted toward packaging, elevating Onto’s structural relevance relative to traditional front-end equipment.
3. Front-End Metrology: In leading-edge fabs, Onto’s OCD and acoustic metrology tools measure gate profiles, 3D NAND channel hole depths, and advanced Gate-All-Around (GAA) structures, competing selectively against broad-line process control vendors.

---

2. Competitive Landscape: Onto vs. KLA and Applied Materials

Onto does not compete head-to-head across the entire process-control footprint. Its competitive survival relies on specialized focus:

| Dimension | Onto Innovation (ONTO) | KLA Corporation (KLAC) | Applied Materials (AMAT) | | :--- | :--- | :--- | :--- | | Primary Domain | Advanced packaging, specialty metrology, macro inspection | Front-end patterned wafer inspection, reticle inspection, OCD | Deposition, etch, CMP; selective inspection/metrology | | Market Share Stance | Category leader in 2.5D/3D packaging & HBM inspection | Dominates ~55%+ of global front-end process control | Broad-line WFE supplier; metrology is ancillary to processing tools | | R&D Scale | ~$130M–$160M annually | >$1.2B annually | >$3.0B annually | | Competitive Moat | High switching costs in packaging lines; software integration | Massive patent portfolio; broadband optical dominance | Bundled tool suites across multi-step fab lines |

• KLA’s Shadow: KLA remains the primary long-term threat. If KLA chooses to aggressively prioritize advanced packaging inspection over its high-margin front-end tools, it could pressure Onto's margins. However, Onto’s installed base across major OSATs (Outsourced Semiconductor Assembly and Test) and foundries provides high switching friction.
• Customer Concentration: Onto’s revenue is heavily concentrated among the top global semiconductor manufacturers and packaging providers: TSMC, Intel, Samsung, SK Hynix, and major OSATs like ASE Group. Loss of tool-of-record status at any single tier-one customer would impair consolidated operating results.

---

3. Financial Architecture, Margins, and Balance Sheet

Onto operates a capital-light, high-gross-margin business model characteristic of specialized equipment manufacturers:

• Gross Margin Profile: Structurally runs between 51% and 54%, driven by proprietary optical sensors and high-margin software licenses (Discover enterprise software).
• Operating Margins: Highly cyclical. During peak WFE and packaging cycles, operating margins reach 26% to 28%; during semiconductor downcycles, operating margins compress toward 15% to 18% as operating leverage works in reverse.
• Balance Sheet Strength: Onto maintains an exceptionally conservative balance sheet with zero long-term funded debt and substantial cash, cash equivalents, and marketable securities (typically between $600M and $800M). This pristine liquidity ensures solvency through severe industry downturns.
• Free Cash Flow Conversion: FCF conversion typically tracks 75% to 90% of net income, supported by modest maintenance capital expenditures (typically under 4% of revenue).

---

4. Exposure to AI Infrastructure Spending and Capex Cycles

Onto’s recent multi-year performance has been propelled by the global buildout of AI accelerators:

• HBM and Packaging Tailwinds: Every modern AI accelerator (such as NVIDIA’s Hopper/Blackwell or AMD’s Instinct) requires multiple HBM stacks linked via advanced packaging. Onto has been a direct beneficiary as foundries and memory producers scramble to expand packaging capacity.
• The Cyclical Vulnerability: If cloud hyperscalers moderate their capital spending, fab utilization and packaging expansion will slow abruptly. In prior semiconductor cycles, equipment orders have dropped 30% to 50% from peak to trough. Investors treating current peak AI packaging demand as a permanent baseline run the risk of overestimating normalized cash flow.

---

5. Intrinsic Value Appraisal

To evaluate Onto Innovation, we must normalize its cash generation across an entire 5-year semiconductor equipment cycle rather than annualizing peak upcycle earnings.

• Normalized Revenue Baseline: ~$1.05 billion to $1.15 billion.
• Normalized Operating Margin: 22.0% (generating ~$240 million in mid-cycle operating income).
• Normalized Free Cash Flow: ~$185 million to $210 million.

┌────────────────────────────────────────────────────────────────────────┐
│                   ONTO INTRINSIC VALUE SCENARIOS                       │
├────────────────────────────────────────────────────────────────────────┤
│  Conservative / Downcycle Case: $100 - $115 per share                  │
│  • Hyperscaler AI capex pause, packaging digestion, 18x FCF + cash     │
│                                                                        │
│  Base Case (Mid-Cycle Normalization): $150 - $170 per share            │
│  • 10% secular packaging CAGR, 22% operating margin, 24x FCF + cash    │
│                                                                        │
│  Optimistic / Sustained AI Boom Case: $210 - $230 per share            │
│  • Advanced packaging adoption spreads to mainstream PC/mobile, 28x    │
└────────────────────────────────────────────────────────────────────────┘

1. Conservative Case (Capex Digestion):
   • Hyperscalers freeze data center expansion; memory makers halt HBM packaging additions; WFE spending contracts.
   • Free cash flow drops to ~$160 million. Valued at 18x FCF plus ~$15/share in net cash yields $100 to $115 per share.
2. Base Case (Long-Term Secular Packaging Growth):
   • Advanced packaging remains a structural growth driver even through periodic memory cycles. Revenue grows at a 9% to 11% compound rate.
   • Free cash flow normalizes near ~$200 million. Valued at 24x mid-cycle FCF plus net cash yields $150 to $170 per share.
3. Optimistic Case (Advanced Packaging Ubiquity):
   • High-density chiplet packaging expands rapidly from AI accelerators into standard enterprise servers, automotive, and premium client computing. Onto defends its tool-of-record status against KLA.
   • Free cash flow expands toward ~$280 million. Valued at 28x peak FCF yields $210 to $230 per share.

---

Fundamental Verdict

Onto Innovation is a technologically capable franchise with an entrenched position in advanced packaging metrology, backed by a fortress balance sheet with zero debt.

However, semiconductor capital equipment is deeply cyclical. When the broader market trades equipment vendors at high multiples on peak-cycle earnings, margin of safety evaporates.

• Entry Strategy: To achieve a 25% to 30% margin of safety against conservative mid-cycle earnings, an attractive accumulation point lies at or below $110 to $120 per share.
• Conclusion: Onto Innovation deserves a permanent spot on an investor’s watch list as one of the premier pure-plays on packaging complexity. However, capital deployment should wait for an inevitable cyclical downturn in semiconductor capex that derates the valuation closer to its conservative asset and normalized cash-flow floor.